KRAS and lung cancer: To ascertain whether Mga functions as a tumor suppressor in vivo, we utilized CRISPR-CAS technology to inactivate Mga in a KrasLSL-G12D/+ (henceforth termed Kras) driven mouse model of lung cancer (Jackson et al., 2001; Sánchez-Rivera et al., 2014).